Categories
Latest Industry Intelligence
DDW has published the first of its new Guide Series, Where is the global innovation [...]
Precision medicine uses information about an individual’s genes, proteins, and environment to prevent, diagnose, and [...]
4D pharma has released additional positive data from its completed Phase II trial of LBP Blautix in subjects with irritable bowel syndrome with constipation (IBS-C) or with diarrhoea (IBS-D). The data has been presented in a poster session at Digestive Disease Week (DDW), on May 22, 2021, by Professor Eamonn Quigley, Head of Gastroenterology and […]
Menu ≡ ╳ 
